Unlike other GHRPs, Ipamorelin has been shown in animal models to exhibit high selectivity for growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels
Classified as a new class of medication, the drug is administered once weekly as an injection under the skin (US FDA 2023
Finally, our studies provide important insights for efforts aimed at development of therapeutic interventions designed to inhibit dietary L-carnitine conversion into TMAO in humans. References: l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans
Grahame, R., Bird, H
Long-term considerations and sustainability Weight loss is only part of the challenge
Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders of pregnancy, gestational diabetes, have a preterm birth or cesarean delivery, researchers reported